The HABITS study, prematurely terminated due to alarming results, showed that after a 2-year follow-up, there was a more than 2-fold increase in the risk of breast cancer recurrence in women who received hormone replacement therapy with estrogen and progestogen-based compounds [12]. The ...
Vaginal atrophy, a manifestation of estrogen deprivation after the menopause, could affect up to 60% of women, with a significant impact on their quality of life. It is often under-diagnosed and inadequately treated. Symptoms are more common and severe in breast cancer survivors. Systemic ...
Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills J Sex Med, 4 (2007), pp. 1679-1683 View PDFView articleCrossrefView in ScopusGoogle Scholar 5 A.L. Berglund, L. Nigaard, E. Rylander Vulvar pain, sexual behavior and genital infections in a young population: A pilo...
(HGF), insulin-like growth factor (IGF), insulin, erythropoietin (EPO), and colony stimulating factor (CSF). Examples of suitable hormone medium additives are estrogen, progesterone, testosterone or glucocorticoids such as dexamethasone. Examples of cytokines are interferons, interleukins, or tumor ...
Another common form of alopecia is hair loss secondary to endocrine therapy in patients with breast cancer (Endocrine Therapy-Induced Alopecia or ETIA). Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors (AIs) currently hold an important place as adjuvant endocrine therapy for pati...
The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer. 图片(4)权利要求(9) 1. A method for treating a woman patient suffering osteoporosis comprising administrating to the patient a therapeutically ...
Breast Cancer PreventionFenretinideTamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Tamoxifen's approval for breast cancer risk reduction dates...
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drugdoi:10.1186/bcr3233Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the ...
Presents letters from readers relating to articles published in the 'British Journal of Surgery.' Letter written by R.M. Jindal regarding patients with chronic pancreatitis; References used by Jindal; Correspondence sent by C. Palmieri on the significance of estrogen receptor beta in breast cancer....
Endoxifen (EDX) is an active metabolite of tamoxifen that has been proven effective in the prevention and treatment of estrogen-positive breast cancer; however, oral administration of tamoxifen often causes severe side effects. Here, the topical delivery of EDX is explored using polymeric micelles ...